Ashurst

The High Court won't hear Bayer's appeal of an invalidity finding over patents for blood thinner Xarelto, despite the company's claim the decision has "profound" consequences for drug R&D.

Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.

A Tasmanian community group has lost its challenge to a decision approving the construction of a wharf to facilitate the transport of hundreds of 86 metre-long wind turbine blades for a controversial wind project on Robbins Island.

A key issue in the ACCC's price-fixing case against Downer EDI's Spotless and Ventia is likely to focus on whether the facilities services companies were in competition, a court has heard. 

A judge has signalled he will approve a $500,000 settlement in an underpayments class action against labour hire company Stellar Personnel, but has grilled the applicant's law firm over costs.

A newly appointed judge has disqualified himself from hearing a group of cases over Greensill’s $1.7 billion collapse, after he acted as counsel for insurer Marsh in a related dispute. 

A judge has warned the lawyers for the owners of the City Mutual Building in Sydney's CBD about failing to comply with court directions, saying their "inexcusable" delay in providing evidence could not be forgiven just because it was a compulsory acquisition matter.

Wine producer Accolade has won a dispute with Pernod Ricard over interim arrangements to distribute wine after it bought the French winemaker’s Australian and New Zealand businesses.

Deputy Prime Minister Richard Marles' chief of staff has called out her boss for “quibbling” in her case alleging she was pushed out after complaining about bullying.

Greensill has a "clear case" for recusal of a judge poised to hear cases over its $1.7 billion collapse, who previously acted as senior counsel for insurer Marsh in a satellite dispute.